Administration of dexamethasone to pregnant rats at 19 days gestation increased phosphatidylcholine synthesis (45%) from radioactive choline in type II cells. This enhanced synthesis of phosphatidylcholine was accompanied by an increased conversion of choline phosphate into CDP-choline. Similar results were obtained by incubating organotypic cultures of 19-day-fetal rat lung with cortisol. The increased conversion of choline phosphate into CDP-choline correlated with an enhanced choline-phosphate cytidylyltransferase activity (31 % after dexamethasone treatment; 47 O after cortisol exposure) in the cell homogenates. A similar increase (26% after dexamethasone treatment; 39% after cortisol exposure) was found in the microsomal-associated enzyme. No differences in cytosolic enzyme activity were observed. The specific activity of the microsomal enzyme was 3-4 times that of the cytosolic enzyme. Most of the enzyme activity was located in the microsomal fraction (58-65%). The treatments had no effect on the total amount of enzyme recovered from the cell homogenates. These results, taken collectively, are interpreted to indicate that the active form of cytidylyltransferase in type II cells is the membrane-bound enzyme and that cytidylyltransferase activation in type II cells from fetal rat lung after maternal glucocorticoid administration occurs by binding of inactive cytosolic enzyme to endoplasmic reticulum.
INTRODUCTION
Pulmonary surfactant present in the alveolar lining layer prevents alveolar collapse and transudation of fluid at low lung volumes (Goerke, 1974) . The ability of pulmonary surfactant to lower the surface tension at end expiration is of critical importance at birth (Avery & Mead, 1959) . The production of surfactant is stimulated near term (Perelman et al., 1981) . During this period the content of lung phosphatidylcholine increases dramatically (Rooney et al., 1976) , and this increase is correlated with enhanced rates of phosphatidylcholine synthesis (Maniscalco et al., 1978) . Numerous studies have suggested that lung maturation, especially the onset of surfactant synthesis, is regulated by endogenous glucocorticoids (Ballard, 1982) . Glucocorticoids stimulate pulmonary phosphatidylcholine synthesis, and it appears that this effect is mediated by an activation of choline-phosphate cytidylyltransferase (EC 2.7.7.15) (Rooney et al., 1979; Possmayer et al., 1979; Brehier & Rooney, 1981) . We have demonstrated that the glucocorticoid action on surfactant-associated phosphatidylcholine synthesis occurs ultimately at the level of the alveolar type II cells and involves a fibroblast-derived polypeptide, fibroblast-pneumonocyte factor, which stimulates cytidylyltransferase (Post et al., 1986) . This enzyme may regulate the CDP-choline pathway for phosphatidylcholine formation in whole lung and in alveolar type II cells (Tokmakjian & Possmayer, 1981; Post et al., 1982 Post et al., , 1984a . The mechanism of activation of cytidylyltransferase in the lung remains unclear. A number of mechanisms have been proposed, including covalent modification (Radika & Possmayer, 1985) and changes in lipid environment (Weinhold et al., 1981 (Weinhold et al., , 1984 . The latter studies suggested that cytidylyltransferase was regulated by a redistribution of enzyme between cytosol and endoplasmic reticulum. The activity of the cytosolic form of the enzyme was low compared with that of the microsomal form (Weinhold et al., 1981) , and enzyme activation occurred by association of the inactive cytosolic enzyme with endoplasmic membranes (Weinhold et al., 1981 (Weinhold et al., , 1984 . A redistribution-activation mechanism for controlling cytidylyltransferase activity has been observed in various cells (Sleight & Kent, 1983; Vance & Pelech, 1984; Wright et al., 1985) . Consequently, I examined whether the stimulation of cytidylyltransferase activity in fetal lung after maternal administration of glucocorticoids occurs in the type II cells and is regulated by a translocation mechanism.
M. Post sponges to form organotypic cultures. The cultures were incubated in MEM containing 10% (v/v) fetal-calf serum and placed in an atmosphere of 5% CO2 in air at 37 'C.
After 20 h of incubation, the cultures were used for incorporation or enzyme studies.
Glucocorticoid treatment
On day 19 of gestation, pregnant rats were injected intraperitoneally with dexamethasone (0.2 mg/kg) in dimethyl sulphoxide. Controls were similarly injected with vehicle alone. Approx. 24 h after the injections, the fetuses were delivered by hysterotomy, killed, and their lungs isolated. The freshly excised lungs were used for the preparation of organotypic cultures as described above. After 20 h of culture, the type II cells were isolated (Post et al., 1984c) and the cells were resuspended in 0.145 M-NaCl/50 mM-Tris/HCl (pH 7.4)/50 mM-NaF/ 2.5 mM-EDTA (hereafter termed 'Tris/saline'). The cells were ruptured with 50 strokes of a Dounce homogenizer and then subjected to subcellular fractionation.
For the study of the effect of cortisol on the cytidylyltransferase activity of type II Pulse-chase studies Organotypic cultures prepared from lungs of 19-dayfetal rats were incubated in MEM supplemented with 1 #uCi of [Me-3H]choline/ml. After 20 h of incubation the radioactive medium was removed and the cultures were washed with unlabelled MEM. The cultures were incubated in MEM in the presence or absence of 100 nM-cortisol, and the type II cells were isolated from the cultures 24 h after the addition of cortisol. The cell suspension was extracted with chloroform/methanol (1:2, v/v) and phosphatidylcholine was isolated. The aqueous layer remaining after the lipid extraction was analysed for choline-containing compounds. Measurement of choline-containing metabolites A sample (250 ,ul) of the aqueous layer (2.5 ml) remaining after the lipid extraction was subjected to h.p.l.c. on an ion-exchange column (Aminex A-27) in an isocratic mode (Mazzola & Kent, 1984) . The choline phosphate and CDP-choline fractions were recovered from the column in scintillation vials and assayed for radioactivity.
Other methods
The protein concentrations were measured by the Bradford assay (Bradford, 1976; Spector, 1978) , with bovine serum albumin as standard. Radioactivity was measured in an Aquasol-based (New England Nuclear) scintillation system.
RESULTS
The effect of maternal dexamethasone administration on choline incorporation into phosphatidylcholine and choline-containing metabolites by type II cells is shown in Fig. 1 . Dexamethasone treatment increased phosphatidylcholine synthesis by approx. 45%. This increase correlated with a significant decrease in the ratio of radioactive choline phosphate to CDP-choline, indicating that choline-phosphate cytidylyltransferase activity was stimulated by the treatment.
The activity of choline-phosphate cytidylyltransferase in subcellular fractions of fetal lung type II cells from control and dexamethasone-treated rats is shown in Table 1 . The specific activity in the microsomal fraction was 4 times that in the cytosol. As shown in Fig. 2 , approx. 65% of the total activity was recovered in the microsomal fraction. It should be noted that about 75.0 + 1.6% (mean + S.E.M.) of total cytidylyltransferase activity was recovered, whereas complete recovery of protein was achieved. Dexamethasone increased the activity of cytidylyltransferase in the post-mitochondrial supernatant of the fetal type II cells by approx. 310% (Table 1) . A similar increase was found in the microsomal fraction, whereas no differences were observed between the cytosolic fractions of type II cells from control and treated fetal rat lungs. Dexamethasone had no significant effect on the subcellular distribution of cytidylyltransferase (Fig. 2) . However, the results showed a trend in the direction of a shift of activity from cytosol to microsomal fraction. In addition, the recovery of In previous studies, we have found that glucocorticoids act indirectly on the type II cells (Post et al, 1984b; Floros et al., 1985; Smith, 1979 (Fig. 3) . This observation indicates again that cortisol stimulates the cytidylyltransferase activity in fetal type II cells. The stimulation of the activity by cortisol is most likely mediated by fibroblast-pneumonocyte factor (Post et al., 1986) . Table 2 shows that exposure of organotypic cultures to cortisol resulted in a significant increase in specific activity in the post-mitochondrial supernatant (47 % ) and in the microsomal fraction of the type II cells (39 % ). The cortisol treatment did not affect the distribution of the enzymic activity (Fig. 4) . Most of the activity was located in the microsomal fraction (approx. 5800). 
<0.001
Again, a trend in the direction of a translocation of activity from cytosol to microsomal fraction was observed. Furthermore, cortisol had no significant effect on the recovery ofcholine-phosphate cytidylyltransferase (control, 88.7 + 4.5; cortisol, 75.8 + 2.7; mean + S.E.M.).
DISCUSSION
In this paper I provide evidence that increased surfactant-associated phosphatidylcholine synthesis, which occurs after maternal dexamethasone administration (Rooney et al., 1976 (Rooney et al., , 1979 Gross et al., 1980 Gross et al., , 1983 Post et al., 1986) , involves an activation of choline-phosphate cytidylyltransferase in the fetal type II cells. This enhancement in cytidylyltransferase activity was observed in total cell homogenates (post-mitochondrial supernatant) as well as in the microsomal fraction, but was not found in the cytosol. The latter contradicts a preliminary report by Viscardi et al. (1985) , who reported that dexamethasone and tri-iodothyronine increased cytidylyltransferase activity in the cytosolic fraction of fetal rat lung type II cells. Activation of cytosolic cytidylyltransferase has also been described for fetal rabbit lungs after oestrogen treatment (Chu & Rooney, 1985) . The increase was mediated by endogenous phospholipids (Chu & Rooney, 1985) . However, studies with type II cells from fetal rabbit lung have demonstrated that exposure to fatty acids results preferentially in an enhancement of microsomal enzymic activity (Aeberhard et al., 1986) .
My observation that the microsomal specific activity of cytidylyltransferase was approx. 4 times the cytosolic specific activity is in agreement with the results obtained with the fetal rabbit type II cells (Aeberhard et al., 1986 translocation of cytidylyltransferase in type II cells after glucocorticoid treatment, the subcellular redistribution of the enzyme was not statistically significant. Most of the activity was already located in the microsomal fraction before the treatment. These results do suggest, however, that the glucocorticoid effect is too modest to have a statistically significant impact on the distribution of the enzyme. Subcellular redistribution in association with increased cytidylyltransferase activity has been reported in choline-depleted type II cells from adult rat lung (Tesan et al., 1985) . A translocation of enzyme in the absence of altered enzyme activity was found in adult type II cells incubated in the presence of pulmonary surfactant (Tesan et al., 1985) . In addition, numerous studies with non-pulmonary cells have demonstrated that cytidylyltransferase is regulated by enzymemembrane interactions rather than by changes in the number of enzyme molecules (Sleight & Kent, 1983; Pelech et al., 1983 Pelech et al., , 1984a Vance & Pelech, 1984; Wright et al., 1985) . Several factors have been implicated in the control of cytidylyltransferase binding to membranes. For example, studies with lung (Weinhold et al., 1984) and liver (Pelech et al., 1983) have demonstrated that fatty acids facilitate the binding of the pulmonary enzyme to microsomal membranes. In addition, studies with type II cells from fetal rabbit lung have shown that an increase in the intracellular concentration of fatty acids resulted in increased phosphatidylcholine synthesis (Aeberhard et al., 1986) . This increase in phosphatidylcholine synthesis was accompanied by an enhanced activity of choline-phosphate cytidylyltransferase in the microsomal fraction. Hence, the involvement of fatty acids in the promotion of cytidylyltransferase binding to endoplasmic-reticulum membranes in fetal type II cells must be considered. On the other hand, although it has been reported that phorbol esters stimulate translocation of cytidylyltransferase in HeLa cells (Pelech et al., 1984b) , no significant release of fatty acids was demonstrated (Cook & Vance, 1985) .
Another mechanism by which cytidylyltransferase association to endoplasmic-reticulum membranes may occur involves a protein-dephosphorylation reaction. Previous studies with liver have suggested that cytidylyltransferase may be interconverted between two forms: a phosphorylated form, which does not bind to membranes, and a dephosphorylated form, which associates with the endoplasmic reticulum (Vance & Pelech, 1984) . A similar regulation mechanism has been suggested for the pulmonary enzyme (Radika & Possmayer, 1985) .
In summary, the effect on surfactant phosphatidylcholine production after maternal glucocorticoid administration is mediated by an activation of cytidylyltransferase in type II cells. The augmented cytidylyltransferase activity can be explained most easily through a translocation of the enzyme from cytosol to the microsomal fraction. Further experiments are needed for confirmation and for the identification of factors involved in the translocation process.
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